Back to search

Article

Nifuroxazide Ameliorates Pulmonary Fibrosis By Blocking Myofibroblast Genesis And Stat3 Activation: A Drug Repurposing Study

2021-06-15

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Idiopathic pulmonary fibrosis (IPF) is a lung disease with complex pathogenesis, high mortality. The development of new drugs is time-consuming and laborious, and the research on new use of old drugs can save time and clinical costs and even avoid serious side effects. Nifuroxazide (NIF) was originally used to treat diarrhoea, but in recent years it has been fou...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
014573e0-587d-54df-bc60-1d5cd3e29239
DOI
10.21203/rs.3.rs-557091/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nifuroxazide Ameliorates Pulmonary Fibrosis By Blocking Myofibroblast Genesis And Stat3 Activation: A Drug Repurposing StudyDOI 10.21203/rs.3.rs-557091/v1
Select a neighboring publication to make it the new centre.